Under the slogan ‘A Company That Cares for People and Health,’ we are accelerating the development of therapeutics, starting with treatments for musculoskeletal disorders and expanding into therapies for target diseases such as diabetes and obesity. The Biologics sector is a rapidly growing field worldwide, with an average annual market growth of over 20%. Compared to synthetic drugs, biologics have already been recognized in both academia and industry as more effective for treating severe diseases, with fewer side effects and greater safety.
We advance natural therapeutics with synthetic biology with improved clinical profile showing increased potency, high immune tolerance
Regenerating TissueWe advance natural therapeutics with synthetic biology with improved clinical profile showing increased potency, high immune tolerance
We aim to set a new standard of care for degenarative dieseases, which eases the burden on patients and transforms healthcare systems
Transforming HealthcareWe aim to set a new standard of care for degenarative dieseases, which eases the burden on patients and transforms healthcare systems
With continuous innovation through design-augmented AI we are committed to achieving groundbreaking drug development
Continuous InnovationWith continuous innovation through design-augmented AI we are committed to achieving groundbreaking drug development
Our vision is to harness the power of advanced synthetic biology to regenerate tissue, treat degenerative diseases, and fundamentally transform healthcare through disease-modifying therapeutics that reduce societal burden.
By inventing new molecules, we aim to transform the treatment of age-related degeneration by developing regenerative therapies that restore tissue function rather than merely alleviating symptoms. By addressing the underlying causes of conditions like osteoarthritis and spinal degeneration, our therapies can improve quality of life for patients and families, help maintain independence, and extend healthy lifespans.
Beyond the individual impact, these treatments have the potential to reduce the long-term societal and healthcare burden by minimizing reliance on chronic medications, repeated surgeries, and prolonged care.
We are accelerating the development of these therapeutics, beginning with musculoskeletal disorders and potentially expanding into additional disease areas. Biologics are widely recognized in both academia and industry for their superior efficacy and safety compared to traditional drugs, offering transformative solutions for severe and complex conditions.
In short, our vision is to redefine what medicine can achieve by Curing Better Than Mother Nature ®
We advance natural therapeutics with synthetic biology with improved clinical profile showing increased potency, high immune tolerance
Regenerating TissueWe advance natural therapeutics with synthetic biology with improved clinical profile showing increased potency, high immune tolerance
We aim to set a new standard of care for degenarative dieseases, which eases the burden on patients and transforms healthcare systems
Transforming HealthcareWe aim to set a new standard of care for degenarative dieseases, which eases the burden on patients and transforms healthcare systems
With continuous innovation through design-augmented AI we are committed to achieving groundbreaking drug development
Continuous InnovationWith continuous innovation through design-augmented AI we are committed to achieving groundbreaking drug development
Company Info
